Trials / Terminated
TerminatedNCT00480948
Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants
Effects of InFat™ Product (High Sn-2 Palmitic Acid) on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants: a Triple-blind, Randomized, Placebo-controlled Trial
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 1 Day – 8 Days
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the efficacy of infant formula having proportion of palmitate in the sn-2 position comparable to human milk in Chinese term infants.
Detailed description
In human breast milk, and in most infant formulas more than 98% of this milk fat is in the form of triglycerides, which contain saturated and unsaturated fatty acids esterified to glycerol. Fatty acids in human milk-fat have a highly specific positional distribution on the glycerol backbone and this specific configuration is known to have a major contribution to the efficacy of this nutrient absorption. Palmitic acid (C16:0), the major saturated fatty acid, is predominantly esterified to the sn-2 (β) position of the triglyceride in human milk. In contrast, palmitic acid in standard infant formulas is esterified to the sn-1 and sn-3 positions. Infants fed with high sn-2 palmitic acid formula had softer stools, less constipation and better calcium absorption as compared to standard infant formula. InFat™ is structured triglyceride fat ingredient with high levels of palmitic acid at sn-2 position. The primary objective of this trial is to demonstrate that feeding Chinese term infants, with formula having proportion of palmitate in the sn-2 position comparable to human milk, reduces calcium-soaps formation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Infant formula feeding (InFat™) | Infant formula with InFat™ oil (containing \~49% of C16:0 at sn-2 position), 24 wk |
| DIETARY_SUPPLEMENT | Control | Standard vegetable oil based infant formula |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-04-01
- Completion
- 2009-08-01
- First posted
- 2007-05-31
- Last updated
- 2011-06-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00480948. Inclusion in this directory is not an endorsement.